2010
DOI: 10.1016/j.taap.2010.04.016
|View full text |Cite
|
Sign up to set email alerts
|

Disruption of Smad-dependent signaling for growth of GST-P-positive lesions from the early stage in a rat two-stage hepatocarcinogenesis model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 42 publications
0
11
0
Order By: Relevance
“…Tumor-promoting potential of hepatocarcinogens in a rat two-stage hepatocarcinogenesis model correlates well with their hepatocarcinogenic potential (Shirai, 1997). In our previous study, we found that TAA and FB had higher tumor promoting potential than PBO (Ichimura et al, 2010). MEG is a strong hepatocarcinogen that has shown induction of hepatocellular adenomas and carcinomas in rats by repeated oral administration at 300 mg/kg/day even at the one-year interim sacrifice (NTP, 2000).…”
Section: Discussionmentioning
confidence: 80%
See 1 more Smart Citation
“…Tumor-promoting potential of hepatocarcinogens in a rat two-stage hepatocarcinogenesis model correlates well with their hepatocarcinogenic potential (Shirai, 1997). In our previous study, we found that TAA and FB had higher tumor promoting potential than PBO (Ichimura et al, 2010). MEG is a strong hepatocarcinogen that has shown induction of hepatocellular adenomas and carcinomas in rats by repeated oral administration at 300 mg/kg/day even at the one-year interim sacrifice (NTP, 2000).…”
Section: Discussionmentioning
confidence: 80%
“…TAA (400 ppm in diet), FB (3,600 ppm in diet), PBO (20,000 ppm in diet), or MEG (1,000 mg/kg body weight, daily by gavage) was administered to target the liver. The dose of these compounds has shown to induce liver tumors or promote liver carcinogenesis in rats (Shoda et al, 1999;NTP, 2000;Muguruma et al, 2007;Ichimura et al, 2010). APAP (12,500 ppm in diet) and ANIT were used as non-hepatocarcinogenic control compounds, and the dose Fig.…”
Section: Methodsmentioning
confidence: 99%
“…Thioacetamide (TAA) is an organosulfur, white crystalline compound having liver damaging and carcinogenic activity by causing cytomegaly. 1 It is used to induce an acute liver injury in rats. TAA gets metabolized to thioacetamide-S-oxide and acetamide immediately after administration to rats.…”
Section: Introductionmentioning
confidence: 99%
“…The nuclear localisation of GST-π may have a major functional impact by protecting the tumour cell from DNA damage and reducing apoptotic cell death induced by external stress and/or therapy. In a rat model of liver carcinogenesis, the disruption of tumour suppressor functions of Smad-dependent signalling is observed in nuclear GST-π positive proliferative lesions, thus suggesting a close link between aberration in the Smaddependent signalling and GST-π (26).…”
Section: Discussionmentioning
confidence: 96%